Cargando…
Anti-programmed cell death-1 (PD-1) monoclonal antibodies involve reversible cranial dura matter
This case is the first document to describe a patient receiving anti-programmed cell death 1 (PD-1) antibodies which showed cranial dura matter involvement. According to the increasing use of anti-PD-1 monoclonal antibodies, adverse effects can occur in several organs since its ligand PD-L1 and PD-L...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436277/ https://www.ncbi.nlm.nih.gov/pubmed/34527250 http://dx.doi.org/10.1093/omcr/omab077 |